Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
You can save money and still enjoy life. Discover creative ways to balance your lifestyle with your financial goals.
27,563 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
On Thursday, Vertex stock surged nearly 6% after a positive analyst note. This guide breaks down what drove the move,...
A notable hedge fund just put $20 million into BlackLine. Is this the spark a turnaround scenario needs, or a cautiou...
A Danish Seahawk helicopter evacuated a U.S. submariner off Nuuk for urgent medical care, a rare Arctic-incident that...
A prominent hedge fund reduced its Wix stake by 25,000 shares in late 2025. This article breaks down what dorsal capi...
Tesla’s shares fall in 2026 as Reddit users grow increasingly bearish, prompting a broader rethink of the EV leader’s...
C3.ai reports after the bell, with traders watching for signals on revenue, margins and AI platform uptake. This live...
Crescent Capital BDC offers a high-yield opportunity along with risks linked to debt investments. This guide breaks d...
As markets swing in early 2026, three actively-managed ETFs are drawing inflows for steady income and downside protec...
Nexa Lending’s Loren Riddick outlines how policy reform could reshape the HECM program, addressing reverse-to-reverse...
As Archer Aviation moves toward broader commercial programs, investors need a clear view of 2025 earnings drivers. Th...
Volatility can create buying opportunities. Here's one hypergrowth tech stock 2026 pick that blends AI momentum, scal...